Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A Post author: Post published:September 25, 2023 Post category:uncategorized The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO. You Might Also Like Cushing’s Syndrome: How Cortisol May Be A Hidden Cause of High Blood Sugar in Diabetes March 18, 2024 The science behind children’s tendency to gather excessive information August 27, 2024 Cosmic radiation and microgravity linked to erectile dysfunction in astronauts November 22, 2023
Cushing’s Syndrome: How Cortisol May Be A Hidden Cause of High Blood Sugar in Diabetes March 18, 2024